Aclaris Therapeutics, Inc. (LON:0H8T)

Aclaris Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	114	212	58	872	657	203
Market Cap Growth	83.53%	263.06%	-93.30%	32.58%	223.25%	244.36%
Enterprise Value	-24	76	-87	668	480	175
Last Close Price	1.07	1.92	0.83	12.36	10.62	5.13
PS Ratio	8.30	14.18	2.38	35.30	131.67	42.84
PB Ratio	1.02	1.71	0.47	5.32	4.51	7.38
P/TBV Ratio	1.02	1.71	0.47	5.51	4.68	9.10
EV/Sales Ratio	-	5.06	-	27.04	96.09	36.79
Debt / Equity Ratio	0.02	0.02	0.02	0.01	0.02	0.38
Asset Turnover	0.10	0.09	0.14	0.12	0.04	0.08
Quick Ratio	4.91	3.88	3.86	9.94	8.38	3.69
Current Ratio	5.06	3.99	4.16	10.56	8.94	3.87
Return on Equity (ROE)	-91.03%	-84.46%	-49.88%	-44.01%	-77.33%	-95.12%
Return on Assets (ROA)	-18.20%	-15.72%	-31.67%	-21.04%	-25.38%	-35.87%
Return on Capital (ROIC)	-23.19%	-20.59%	-39.70%	-26.60%	-32.43%	-48.16%
Earnings Yield	-88.26%	-49.76%	-118.96%	-8.28%	-10.21%	-18.37%
FCF Yield	-8.37%	-7.61%	-107.07%	-6.49%	-5.89%	-14.08%
Buyback Yield / Dilution	-27.19%	-10.73%	-7.05%	-14.95%	-33.36%	-2.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.